Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2010
11/24/2010CN101889978A Pharmaceutical composition containing vinpocetine, preparation method and application thereof
11/24/2010CN101889974A Chitosan contraceptive gel and preparation method thereof
11/24/2010CN101889973A Itraconazole gel for dogs and preparation method thereof
11/24/2010CN101889972A Preparation of TCH/HNTs/PLGA nanometer composite fibre medicine carrying system
11/24/2010CN101889958A Freeze-dried composition
11/24/2010CN101327187B Nonoxynol nonylphenoxy-polyethoxyethanol suppositorium and preparation method thereof
11/24/2010CN101274100B Method for preparing adriamycin-dipeptide complexes and applications
11/24/2010CN101259115B Orally-administered insulin soft capsule for treating diabetes and preparation thereof
11/24/2010CN101239075B Blood platelet aqueous products
11/24/2010CN101234116B Powder needle injection containing caderofloxacin lactate
11/24/2010CN101234115B Water needle injection containing caderofloxacin lactate
11/24/2010CN101229140B Nifedipine sustained release preparation and preparing method thereof
11/24/2010CN101222939B Preservative composition for ophthalmic use
11/24/2010CN101167730B Compound betamethasone suspension injection
11/24/2010CN101152189B Polyene phosphatidyl choline injection and method for preparing the same
11/24/2010CN100998595B Medicine composition containing cefateram cyclodextrin capsule and its preparing method
11/23/2010US7840263 Method and apparatus for device controlled gene expression
11/23/2010US7838699 Embolization using degradable crosslinked hydrogels
11/23/2010US7838619 Biodegradable polyketal polymers and methods for their formation and use
11/23/2010US7838595 high purity; storage stability; electrophilically activated polymer derivatives with aldehyde functionality for conjugating to biologically active molecules; drug-polymer conjugate;
11/23/2010US7838592 Starch-based coating composition
11/23/2010US7838558 adapalene in topical gels, creams or lotions in higher concentration for skin disorders such as acne
11/23/2010US7838555 Useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and
11/23/2010US7838527 Methods of treating cancer and related methods
11/23/2010US7838511 With a phospholipid such as dipalmitoyl phosphatidylcholine, and an antiinflammatory drug such as a nonsteroidal, anti-inflammatory drug (NSAID) such as celecoxib
11/23/2010US7838509 Methods and compositions to improve germ cell and embryo survival and function
11/23/2010US7838491 controlling hydroxyapatite crystal growth; stabilized cylindrical micelles; bone disorders
11/23/2010US7838289 Assay utilizing multipotent adult stem cells
11/23/2010US7838055 microcrystallization of xylitol and maltitol via spraying liquid feed thereof, evaporating solvent, conditioning, milling; for use in confectionery, foodstuffs, oral hygiene products and pharmaceuticals and dietetic
11/23/2010US7838037 of active ingredients for topical use; dissolving active ingredient in ethyl acetate with acrylate copolymer; double-layer and triple-layer microcapsules; oxidation resistance; storage stability
11/23/2010US7838034 Drug(s) partially undissolved in water-based suspending medium with specific particle size; dilution with phosphate buffer; dissolving; paracetamol injection
11/23/2010US7838033 Composition for rapid disintegrating tablet in oral cavity
11/23/2010US7838032 An expectorant drug delivery dosage forms comprises a sustained release portion and an immediate release portion; relieving from bronchial mucus accumulation
11/23/2010US7838027 Pantoprazole multiparticulate formulations
11/23/2010US7838017 have particular physical properties (e.g., molecular weight, concentration, and pH) which address the need for a safe adjuvant for eliciting an enhanced immune response; vaccines
11/23/2010US7838011 a transdermal mixture of collagen, elastin, sphingoside, cerebroside and botulinum toxin
11/23/2010CA2478094C Methods of inducing terminal differentiation
11/23/2010CA2464502C Granules or powder for the production of coating agents and binders for pharmaceutical forms
11/23/2010CA2462085C Cytotoxic agents
11/23/2010CA2444529C Micellar drug delivery systems for hydrophobic drugs
11/23/2010CA2434775C Compounds for use in the treatment of skin conditions
11/23/2010CA2425025C Use of bioactive fraction from cow urine distillate ('go mutra') as a bio-enhancer of anti-infective, anti-cancer agents and nutrients
11/23/2010CA2382133C Phospholipid-based powders for drug delivery
11/23/2010CA2367402C Stable pharmaceutical dosage form for paroxetine anhydrate
11/23/2010CA2354148C Aerosol formulations for buccal and pulmonary application
11/23/2010CA2315271C Platelet derived growth factor (pdgf) nucleic acid ligand complexes
11/23/2010CA2295189C Type-1 ribosome-inactivating protein
11/23/2010CA2252565C Dna vaccine formulations
11/23/2010CA2223989C Prodrugs of pharmaceuticals with improved bioavailability
11/21/2010CA2671921A1 Inclusion complex of raloxifene hydrochloride and .beta.-cyclodextrin
11/19/2010CA2701484A1 Ondansetron film compositions
11/18/2010WO2010132879A2 Multicomponent degradable cationic polymers
11/18/2010WO2010132730A2 Hyaluronic acid (ha) injection vehicle
11/18/2010WO2010132664A1 Compositions and methods for drug delivery
11/18/2010WO2010132474A2 Stable elastomeric negative acoustic contrast particles and their use in acoustic radiation fields
11/18/2010WO2010132471A2 Synthesis of stable elastomeric negative acoustic contrast particles
11/18/2010WO2010132431A1 Orally disintegrating excipient
11/18/2010WO2010132410A2 Solid cosmetic composition with structurant and electrolyte solution
11/18/2010WO2010132047A1 Guanosine/gmp gels and uses thereof
11/18/2010WO2010131907A2 Sirna delivery system using self-assembled polymeric nanoparticles
11/18/2010WO2010131777A1 Fine particles of crystalline polyol and method of preparing same
11/18/2010WO2010131695A1 Modified double-stranded rna
11/18/2010WO2010131675A1 Polymer conjugate of bioactive substance having hydroxy group
11/18/2010WO2010131590A1 Diagnostic agent and therapeutic agent for tumors
11/18/2010WO2010131486A1 Intranasal pharmaceutical compositions with improved pharmacokinetics
11/18/2010WO2010131032A2 Novel polymers
11/18/2010WO2010130799A2 Method for impregnation with supercritical co2
11/18/2010WO2010130428A1 Oil-in-water emulsion of mometasone and propylene glycol
11/18/2010WO2010130396A2 Preparation of acetyl salicylic acid/glutamic acid complex for oral administration
11/18/2010WO2010130053A1 COMPOSITIONS AND METHODS FOR TREATING HEMATOLOGIC CANCERS TARGETING THE SIRPα - CD47 INTERACTION
11/18/2010WO2010111650A3 Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining
11/18/2010WO2010111641A3 Methods for treating and preventing pneumonia and ventilator-associated tracheobronchitis
11/18/2010WO2010111640A3 Anti-influenza formulations and methods
11/18/2010WO2010111533A3 Transdermal delivery of pkc modulatory peptides through microporated skin
11/18/2010WO2010109434A3 A medicinal antibacterial, antifungal and steroids cream comprising chitosan and a process to make it
11/18/2010WO2010106571A3 Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids
11/18/2010WO2010106431A3 High affinity t-cell receptor-like ny-eso-1 peptide antibodies, methods, and uses thereof
11/18/2010WO2010103365A3 Sustained release composition of therapeutic agent
11/18/2010WO2010101627A3 Methods and systems for treatment and/or diagnosis
11/18/2010WO2010077045A3 Pharmaceutical composition of lyophilized formulation and preparation method of the same
11/18/2010WO2010075423A3 Dendrimer based modular platforms
11/18/2010WO2010032165A3 Prodrugs of artemisinin
11/18/2010WO2009151708A3 Peptide analogs of alpha-melanocyte stimulating hormone
11/18/2010WO2009140421A8 Polymeric carrier
11/18/2010WO2009129943A8 Formulation with reduced hygroscopicity
11/18/2010US20100292441 Antibodies that specifically bind to GMAD
11/18/2010US20100292414 High-Molecular Weight Conjugate Of Steroids
11/18/2010US20100292348 Detection of methylated dna and dna mutations
11/18/2010US20100292347 Process to thicken aqueous compositions, notably with an acid ph, by means of organophosphate polymers, and the aqueous compositions obtained
11/18/2010US20100292314 Anti-angiogenic compositions and methods of use
11/18/2010US20100292272 Supramolecular co-colloids produced using macrocyclic polyanionic systems
11/18/2010US20100292195 Low burst polymers and methods to produce polymer
11/18/2010US20100292146 Composite bone repair material
11/18/2010US20100292139 Topical drug delivery using phosphatidylcholine
11/18/2010US20100291218 Immunomodulatory compositions, formulations, and methods for use thereof
11/18/2010US20100291217 Pharmaceutical compositions
11/18/2010US20100291216 Pharmaceutical compositions
11/18/2010US20100291215 Drug delivery matrices to enhance wound healing
11/18/2010US20100291202 Coated pharmaceutical or nutraceutical preparation with enhanced pulsed active substance release
11/18/2010US20100291193 Immunogenic compositions comprising progastrin and uses thereof
1 ... 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 ... 1712